Nasal Sprays Recalled; 75,000 Kaiser Workers Strike; Healthcare AI May Run Amok

Derick Alison
Derick Alison
3 Min Read

Note that some links may require registration or subscription.

Biomic Sciences issued a nationwide recall of all lots of its Ion and Restore nasal sprays after FDA testing discovered microbial contamination.

Some 75,000 health workers at Kaiser Permanente hospitals are now on strike in Virginia, Washington, D.C., California, Colorado, Oregon, and Washington state over wages and staffing levels. (AP)

Previously undisclosed documents revealed an Ethiopian government investigation into WHO Director-General Tedros Adhanom Ghebreyesus, PhD, which he called a “smear campaign.” (Bloomberg)

Nobel prize winner Katalin Karikó, PhD, said the University of Pennsylvania demoted her 10 years ago because she couldn’t get financial support to continue her mRNA research. (The Hill)

What’s next for mRNA technology? (Nature)

Survey data showed the most common reason for not getting boosted last fall was prior SARS-CoV-2 infection, followed by concern about vaccine side effects. (Vaccine)

We’re about to let healthcare AI run amok, a physician argued. (Fortune)

From January 2019 to August 2022, kids’ use of mental health services rose by 22% in the U.S. (JAMA Network Open)

Trans hospital patients in England will be banned from being treated in female-only and male-only wards under plans announced by the health secretary. (The Guardian)

U.S. officials announced criminal charges against Chinese companies and executives accused of supplying precursor chemicals to illegally make fentanyl and other drugs. (AP)

The CDC is no longer distributing COVID-19 vaccination cards. (CNN)

The new COVID vaccine push is “anti-human,” Florida Surgeon General Joseph Ladapo, MD, PhD, told Fox News.

The nine-banded armadillo may be behind a rise in domestic leprosy cases, experts maintained. (USA Today)

Machine learning models predicted who might need lung cancer screening. (PLOS Medicine)

Takeda said it will voluntarily withdraw its lung cancer drug mobocertinib (Exkivity) in the U.S. after a phase III trial did not meet the confirmatory data requirement for accelerated approval.

The Washington Post studied premature death in the U.S., analyzing county-level death records from the past 5 decades. Here’s what it found.

A New Jersey appeals court tossed a $223.8 million verdict against Johnson & Johnson awarded by a jury to four plaintiffs who said they developed cancer after being exposed to asbestos in the company’s talc powder products. (Reuters)

Intakes of sugar-sweetened beverages rose globally between 1990 and 2018, with the largest increase in Sub-Saharan Africa. (Nature Communications)

A new book explored how medical research often ignored female bodies. (NPR)

  • Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more. Follow

Source link

Share this Article
Leave a comment
adbanner